Suppr超能文献

相似文献

5
Significance of KRAS/PAK1/Crk pathway in non-small cell lung cancer oncogenesis.
BMC Cancer. 2015 May 9;15:381. doi: 10.1186/s12885-015-1360-4.
6
Molecular predictors of sensitivity to the MET inhibitor PHA665752 in lung carcinoma cells.
J Thorac Oncol. 2010 Sep;5(9):1317-24. doi: 10.1097/JTO.0b013e3181e2a409.
7
9
c-Met targeting enhances the effect of irradiation and chemical agents against malignant colon cells harboring a KRAS mutation.
PLoS One. 2014 Nov 26;9(11):e113186. doi: 10.1371/journal.pone.0113186. eCollection 2014.
10

引用本文的文献

1
Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures.
Cancer Cell. 2025 Jul 30. doi: 10.1016/j.ccell.2025.07.011.
4
Modulating PAK1: Accessory Proteins as Promising Therapeutic Targets.
Biomolecules. 2025 Feb 7;15(2):242. doi: 10.3390/biom15020242.
5
The amino acid composition of a protein influences its expression.
PLoS One. 2024 Oct 14;19(10):e0284234. doi: 10.1371/journal.pone.0284234. eCollection 2024.
6
Pneumococcal hydrogen peroxide regulates host cell kinase activity.
Front Immunol. 2024 Jun 5;15:1414195. doi: 10.3389/fimmu.2024.1414195. eCollection 2024.
7
modeling of acquired resistance to RTK/RAS-pathway-targeted therapies.
iScience. 2023 Dec 11;27(1):108711. doi: 10.1016/j.isci.2023.108711. eCollection 2024 Jan 19.
8
SOS1 and KSR1 modulate MEK inhibitor responsiveness to target resistant cell populations based on PI3K and KRAS mutation status.
Proc Natl Acad Sci U S A. 2023 Nov 21;120(47):e2313137120. doi: 10.1073/pnas.2313137120. Epub 2023 Nov 16.
9
Therapeutic Targeting of Regulated Signaling Pathways of Non-Small Cell Lung Carcinoma.
ACS Omega. 2023 Jul 17;8(30):26685-26698. doi: 10.1021/acsomega.3c02424. eCollection 2023 Aug 1.
10

本文引用的文献

1
The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013.
Nucleic Acids Res. 2013 Jan;41(Database issue):D1063-9. doi: 10.1093/nar/gks1262. Epub 2012 Nov 29.
3
TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers.
Cell. 2012 Feb 17;148(4):639-50. doi: 10.1016/j.cell.2011.12.033.
4
Targeting MET in cancer: rationale and progress.
Nat Rev Cancer. 2012 Jan 24;12(2):89-103. doi: 10.1038/nrc3205.
5
P-21 activated kinase 1 knockdown inhibits β-catenin signalling and blocks colorectal cancer growth.
Cancer Lett. 2012 Apr 1;317(1):65-71. doi: 10.1016/j.canlet.2011.11.014. Epub 2011 Nov 15.
6
BCL2A1: the underdog in the BCL2 family.
Cell Death Differ. 2012 Jan;19(1):67-74. doi: 10.1038/cdd.2011.158. Epub 2011 Nov 11.
7
Ras history: The saga continues.
Small GTPases. 2010 Jul;1(1):2-27. doi: 10.4161/sgtp.1.1.12178.
8
Phosphoproteomics identifies oncogenic Ras signaling targets and their involvement in lung adenocarcinomas.
PLoS One. 2011;6(5):e20199. doi: 10.1371/journal.pone.0020199. Epub 2011 May 26.
9
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells.
Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7177-82. doi: 10.1073/pnas.1103350108. Epub 2011 Apr 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验